• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型滑动锁生物可吸收聚对二氧环己酮支架的机械性能和体内性能。

Mechanical properties and in vivo performance of a novel sliding-lock bioabsorbable poly-p-dioxanone stent.

机构信息

Children's Heart Center, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China.

出版信息

J Mater Sci Mater Med. 2011 Oct;22(10):2319-27. doi: 10.1007/s10856-011-4407-3. Epub 2011 Aug 6.

DOI:10.1007/s10856-011-4407-3
PMID:21822666
Abstract

A bioabsorbable poly-p-dioxanone (PPDO) stent with a novel sliding-lock structure was fabricated to treat stenotic peripheral vessels. The sliding-lock PPDO stents have greater radial strength (107 kPa) than PPDO stents with conventional net-tube structure (32 kPa). The sliding-lock PPDO stents were implanted into the iliac arteries of pigs, and implantation success rate was 90% indicating the feasibility of this design. Additionally, we found that sliding-lock PPDO stents kept vessels patent, although by 3 and 6 months post implantation, luminal diameter decreased slightly due to intimal hyperplasia. At 1 month post implantation, the stents were sparsely covered with endothelial cells, and by 6 months, the stents were mostly absorbed and inflammatory reaction gradually decreased as the stents were absorbed. This study shows favorable mechanical strength, degradability and efficacy for the sliding-lock PPDO stents, and supports further research and development of this unique design of polymer stents for applications in vascular devices.

摘要

一种具有新型滑动锁定结构的可吸收性聚对二氧环己酮(PPDO)支架被制造出来,用于治疗狭窄的周围血管。滑动锁定 PPDO 支架的径向强度(107kPa)大于具有传统网筒结构的 PPDO 支架(32kPa)。滑动锁定 PPDO 支架被植入猪的髂动脉中,植入成功率为 90%,表明这种设计是可行的。此外,我们发现滑动锁定 PPDO 支架能够保持血管通畅,尽管在植入后 3 个月和 6 个月,由于内膜增生,管腔直径略有减小。在植入后 1 个月,支架上稀疏地覆盖着内皮细胞,而在 6 个月时,支架大部分已被吸收,随着支架的吸收,炎症反应逐渐减少。这项研究表明,滑动锁定 PPDO 支架具有良好的机械强度、可降解性和疗效,支持进一步研究和开发这种用于血管器械的独特聚合物支架设计。

相似文献

1
Mechanical properties and in vivo performance of a novel sliding-lock bioabsorbable poly-p-dioxanone stent.新型滑动锁生物可吸收聚对二氧环己酮支架的机械性能和体内性能。
J Mater Sci Mater Med. 2011 Oct;22(10):2319-27. doi: 10.1007/s10856-011-4407-3. Epub 2011 Aug 6.
2
Bioresorbable PPDO sliding-lock stents with optimized FDM parameters for congenital heart disease treatment.用于先天性心脏病治疗的优化 FDM 参数的可生物吸收 PPDO 滑动锁定支架。
J Mech Behav Biomed Mater. 2023 Feb;138:105609. doi: 10.1016/j.jmbbm.2022.105609. Epub 2022 Dec 7.
3
A novel braided biodegradable stent for use in congenital heart disease: Short-term results in porcine iliac artery.一种新型编织可生物降解支架用于先天性心脏病:在猪髂动脉中的短期结果。
J Biomed Mater Res A. 2019 Aug;107(8):1667-1677. doi: 10.1002/jbm.a.36682. Epub 2019 Apr 12.
4
A new approach to improve the local compressive properties of PPDO self-expandable stent.一种改善聚对二氧环己酮自膨胀支架局部压缩性能的新方法。
J Mech Behav Biomed Mater. 2017 Apr;68:318-326. doi: 10.1016/j.jmbbm.2017.02.015. Epub 2017 Feb 16.
5
In vitro degradation of biodegradable blending materials based on poly(p-dioxanone) and poly(vinyl alcohol)-graft-poly(p-dioxanone) with high molecular weights.基于聚对二氧环己酮和高分子量聚乙烯醇接枝聚对二氧环己酮的可生物降解共混材料的体外降解
J Biomed Mater Res A. 2007 Feb;80(2):453-65. doi: 10.1002/jbm.a.30938.
6
New tubular bioabsorbable knitted airway stent: biocompatibility and mechanical strength.新型管状生物可吸收编织气道支架:生物相容性与机械强度
J Thorac Cardiovasc Surg. 2002 Jan;123(1):161-7. doi: 10.1067/mtc.2002.118503.
7
Six-month evaluation of novel bioabsorbable scaffolds composed of poly-L-lactic acid and amorphous calcium phosphate nanoparticles in porcine coronary arteries.新型聚左旋乳酸和无定形磷酸钙纳米粒子生物可吸收支架在猪冠状动脉中 6 个月的评估。
J Biomater Appl. 2018 Aug;33(2):227-233. doi: 10.1177/0885328218790332.
8
Drug-eluting biodegradable poly-D/L-lactic acid vascular stents: an experimental pilot study.药物洗脱可生物降解聚-D/L-乳酸血管支架:一项实验性初步研究。
J Endovasc Ther. 2005 Jun;12(3):371-9. doi: 10.1583/05-1525.1.
9
Biological compatibility, thermal and in vitro simulated degradation for poly(p-dioxanone)/poly(lactide-co-glycolide)/poly(ethylene succinate-co-glycolide).聚对二氧环己酮/聚(丙交酯-乙交酯)/聚(琥珀酸乙二酯-乙交酯)的生物相容性、热性能及体外模拟降解性能
J Biomed Mater Res B Appl Biomater. 2021 Nov;109(11):1817-1835. doi: 10.1002/jbm.b.34842. Epub 2021 Apr 24.
10
Iliac anastomotic stenting with a sirolimus-eluting biodegradable poly-L-lactide stent: a preliminary study after 6 weeks.使用西罗莫司洗脱可生物降解聚-L-丙交酯支架进行髂动脉吻合口支架置入术:6周后的初步研究
J Endovasc Ther. 2006 Oct;13(5):630-9. doi: 10.1583/06-1899R.1.

本文引用的文献

1
Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents.归因于第一代西罗莫司和紫杉醇洗脱支架的晚期支架血栓形成的冠状动脉反应和不同机制。
J Am Coll Cardiol. 2011 Jan 25;57(4):390-8. doi: 10.1016/j.jacc.2010.05.066.
2
Stent thrombosis and duration of dual antiplatelet therapy.支架血栓形成与双联抗血小板治疗时间
Curr Pharm Des. 2010;16(36):4052-63. doi: 10.2174/138161210794454851.
3
Two-year safety and effectiveness of sirolimus-eluting stents (from a prospective registry).
载有前瞻性注册研究的西罗莫司洗脱支架的两年安全性和有效性。
Am J Cardiol. 2011 Feb 15;107(4):528-34. doi: 10.1016/j.amjcard.2010.10.010. Epub 2010 Dec 31.
4
The evolving role of inflammatory biomarkers in risk assessment after stent implantation.支架植入术后炎症生物标志物在风险评估中的作用演变。
J Am Coll Cardiol. 2010 Nov 23;56(22):1783-93. doi: 10.1016/j.jacc.2010.06.045.
5
Current status of the Xience V® everolimus-eluting coronary stent system.Xience V®依维莫司洗脱冠状动脉支架系统的现状
Expert Rev Cardiovasc Ther. 2010 Oct;8(10):1363-74. doi: 10.1586/erc.10.127.
6
The biocompatibility of rapidly degrading polymeric stents in porcine carotid arteries.快速降解聚合物支架在猪颈动脉中的生物相容性。
Biomaterials. 2010 Nov;31(31):7847-55. doi: 10.1016/j.biomaterials.2010.06.057. Epub 2010 Aug 8.
7
Stenting in congenital heart disease: medium- and long-term outcomes from the JPIC stent survey.先天性心脏病支架置入:JPIC 支架调查的中期和长期结果。
Circ J. 2010 Aug;74(8):1676-83. doi: 10.1253/circj.cj-10-0157. Epub 2010 Jun 29.
8
Sirolimus versus paclitaxel coronary stents in clinical practice.西罗莫司与紫杉醇冠状动脉支架在临床实践中的应用比较。
Catheter Cardiovasc Interv. 2011 Jan 1;77(1):5-12. doi: 10.1002/ccd.22597.
9
The first-generation drug-eluting stents and coronary endothelial dysfunction.第一代药物洗脱支架与冠状动脉内皮功能障碍。
JACC Cardiovasc Interv. 2009 Dec;2(12):1169-77. doi: 10.1016/j.jcin.2009.10.004.
10
Bioabsorbable coronary stents.生物可吸收冠状动脉支架
Circ Cardiovasc Interv. 2009 Jun;2(3):255-60. doi: 10.1161/CIRCINTERVENTIONS.109.859173.